Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (440) 440
life sciences & biomedicine (429) 429
pd‐1 (299) 299
humans (238) 238
pd-1 (193) 193
immunotherapy (184) 184
oncology (166) 166
apoptosis (149) 149
female (133) 133
cancer (126) 126
t cells (126) 126
immune checkpoint (125) 125
lymphocytes (125) 125
immunology (118) 118
male (118) 118
lymphocytes t (115) 115
pd‐l1 (103) 103
tumors (101) 101
animals (95) 95
cell death (91) 91
patients (91) 91
middle aged (86) 86
aged (78) 78
adult (75) 75
pd-l1 (74) 74
analysis (70) 70
cell biology (68) 68
melanoma (63) 63
cd8 antigen (59) 59
ligands (59) 59
care and treatment (58) 58
flow cytometry (58) 58
lung cancer (57) 57
mice (56) 56
antibodies (53) 53
immune system (53) 53
metastasis (52) 52
programmed cell death 1 receptor - immunology (51) 51
chemotherapy (50) 50
metastases (50) 50
programmed cell death 1 receptor - metabolism (50) 50
pembrolizumab (49) 49
clinical trials (48) 48
antigens (47) 47
cytotoxicity (47) 47
programmed cell death 1 receptor - antagonists & inhibitors (47) 47
hematology (46) 46
original (46) 46
cancer therapies (45) 45
nivolumab (45) 45
pathology (43) 43
cd8-positive t-lymphocytes - immunology (42) 42
ctla‐4 (42) 42
prognosis (42) 42
cd4 antigen (40) 40
immunohistochemistry (40) 40
medical research (40) 40
medical prognosis (39) 39
aged, 80 and over (38) 38
biomarkers (38) 38
immune response (38) 38
programmed cell death 1 receptor (38) 38
b7-h1 antigen - metabolism (37) 37
gene expression (35) 35
pd-1 protein (35) 35
cytokines (34) 34
t-lymphocytes - immunology (34) 34
mutation (32) 32
surgery (32) 32
original articles (31) 31
antibodies, monoclonal - therapeutic use (30) 30
antitumor activity (30) 30
health aspects (30) 30
proteins (30) 30
abridged index medicus (29) 29
cell activation (29) 29
cell proliferation (29) 29
survival (29) 29
original article (28) 28
ctla-4 (27) 27
dermatology (27) 27
mice, inbred c57bl (27) 27
b7-h1 antigen (26) 26
inflammation (26) 26
inhibitors (26) 26
interferon (26) 26
neoplasms - immunology (26) 26
b7-h1 antigen - immunology (25) 25
programmed cell death 1 receptor - genetics (25) 25
b7-h1 antigen - antagonists & inhibitors (24) 24
immunoglobulins (24) 24
immunotherapy - methods (24) 24
lymphocyte activation - immunology (24) 24
signal transduction (24) 24
antigens, cd - metabolism (23) 23
cd4-positive t-lymphocytes - immunology (23) 23
immunoregulation (23) 23
pd-l1 protein (23) 23
antineoplastic agents, immunological - therapeutic use (22) 22
dendritic cells (22) 22
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Myocarditis Associated with Immune Checkpoint Inhibitors: An Expert Consensus on Data Gaps and a Call to Action
by Neilan, Tomas G and Rothenberg, Mace L and Amiri‐Kordestani, Laleh and Sullivan, Ryan J and Steingart, Richard M and Gregory, William and Hariharan, Subramanian and Hammad, Tarek A and Lindenfeld, JoAnn and Murphy, Martin J and Moslehi, Javid J and Abdullah, Hesham and Amiri‐Kordestani, Laleh and Bakker, Cecilia and Boshoff, Chris and Bringhurst, Charlie and Bucktrout, Samantha and Carlin, Kathleen and Caubel, Patrick and Chen, Roland and Chin, Kevin and Chudnovsky, Aleksander and Davis, John and Deutsch, Jonathan and Dixit, Rakesh and Gottfridsson, Christer and Gregory, William and Hammad, Tarek A and Handelsman, Dave and Hariharan, Subramanian and Holmes, William and Honig, Peter and Hugh‐Jones, Charles and Kaufman, Howard and Khan, Nasir and Kozono, David and Kwan, Antonia and Lewis‐Hall, Freda C and Ley‐Acosta, Sergio and Lindenfeld, JoAnn and Michelon, Elisabete and Moslehi, Javid J and Murphy, Martin J and Neilan, Tomas G and Patel, Mayur and Pavlovic, Dejan and Pignatti, Francesco and Potter, Jonathan and Reese, David and Rothenberg, Mace L and Safferman, Allan and Silvester, Eliza and Steingart, Richard M and Sullivan, Ryan J and Zhou, Ming and Checkpoint Inhibitor Safety Work and Checkpoint Inhibitor Safety Working Group and on behalf of the Checkpoint Inhibitor Safety Working Group
The oncologist (Dayton, Ohio), ISSN 1083-7159, 08/2018, Volume 23, Issue 8, pp. 874 - 878
Myocarditis | Immune checkpoint inhibitor | Project Data Sphere | PD‐1/PD‐L1 inhibitor | Immune‐related adverse events | Immune-related adverse events | PD-1/PD-L1 inhibitor | Life Sciences & Biomedicine | Oncology | Science & Technology | PD‐L1 inhibitor | 26 | Commentaries | PD‐1
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Adsorption of SF 6 decomposition components over Pd (1 1 1): A density functional theory study
by Liu, Daikun and Gui, Yingang and Ji, Chang and Tang, Chao and Zhou, Qu and Li, Jie and Zhang, Xiaoxing
Applied surface science, ISSN 0169-4332, 01/2019, Volume 465, pp. 172 - 179
Surface adsorption | Pd(1 1 1) adsorbent | SF6 decomposition components | DFT calculations
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Safety and Tolerability of PD‐1/PD‐L1 Inhibitors Compared with Chemotherapy in Patients with Advanced Cancer: A Meta‐Analysis
by Nishijima, Tomohiro F and Shachar, Shlomit S and Nyrop, Kirsten A and Muss, Hyman B
The oncologist (Dayton, Ohio), ISSN 1083-7159, 04/2017, Volume 22, Issue 4, pp. 470 - 479
Systematic review | Chemotherapy | PD‐1/PD‐L1 inhibitor | Meta‐analysis | Toxicity | PD-1/PD-L1 inhibitor | Meta-analysis | Life Sciences & Biomedicine | Oncology | Science & Technology | Carcinoma, Non-Small-Cell Lung - pathology | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Carcinoma, Non-Small-Cell Lung - genetics | Humans | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Melanoma - pathology | B7-H1 Antigen - genetics | Drug-Related Side Effects and Adverse Reactions - pathology | Disease-Free Survival | B7-H1 Antigen - antagonists & inhibitors | Melanoma - genetics | Melanoma - drug therapy | Carcinoma, Non-Small-Cell Lung - drug therapy | Programmed Cell Death 1 Receptor - genetics | Drug-Related Side Effects and Adverse Reactions - classification | Index Medicus | PD‐L1 inhibitor | Symptom Management and Supportive Care | PD‐1
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Combination of Bacterial‐Photothermal Therapy with an Anti‐PD‐1 Peptide Depot for Enhanced Immunity against Advanced Cancer
by Chen, Wenfei and Guo, Zhaofei and Zhu, Yining and Qiao, Nan and Zhang, Zhirong and Sun, Xun
Advanced functional materials, ISSN 1616-301X, 01/2020, Volume 30, Issue 1, pp. 1906623 - n/a
Salmonella | anti‐PD‐1 peptide depot | advanced melanoma | photothermal therapy | PD‐1/PD‐L1 blockade therapy | Materials Science | Materials Science, Multidisciplinary | Physics, Condensed Matter | Science & Technology - Other Topics | Chemistry, Physical | Physics | Science & Technology | Physics, Applied | Physical Sciences | Chemistry | Nanoscience & Nanotechnology | Technology | Chemistry, Multidisciplinary | Therapy | Peptides | Phospholipids | Inoculation | Immunology | Cell death | Lymphocytes | Phase separation | Infrared lasers | Bacteria | Cancer | Tumors | Apoptosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Functional systemic CD4 immunity is required for clinical responses to PD‐L1/PD‐1 blockade therapy
by Zuazo, Miren and Arasanz, Hugo and Fernández‐Hinojal, Gonzalo and García‐Granda, Maria Jesus and Gato, María and Bocanegra, Ana and Martínez, Maite and Hernández, Berta and Teijeira, Lucía and Morilla, Idoia and Lecumberri, Maria Jose and Fernández de Lascoiti, Angela and Vera, Ruth and Kochan, Grazyna and Escors, David
EMBO molecular medicine, ISSN 1757-4676, 07/2019, Volume 11, Issue 7, pp. e10293 - n/a
lung cancer | PD‐1/PD‐L1 | biomarker | B7‐H1 | immunotherapy | B7-H1 | PD-1/PD-L1 | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | A549 Cells | Humans | Middle Aged | Neoplasm Proteins - immunology | Lung Neoplasms - pathology | Male | Lung Neoplasms - therapy | CD4-Positive T-Lymphocytes - pathology | B7-H1 Antigen - immunology | CD4-Positive T-Lymphocytes - immunology | Lung Neoplasms - immunology | Immunotherapy | Female | Immunologic Memory | Aged | Programmed Cell Death 1 Receptor - immunology | Immunity, Cellular | T cells | Lung cancer | Index Medicus | Immunology | PD‐1 | PD‐L1 | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text PD‐1/PD‐L1 Blockade Therapy in Advanced Non‐Small‐Cell Lung Cancer: Current Status and Future Directions
by Xia, Liliang and Liu, Yuanyong and Wang, Ying
The oncologist (Dayton, Ohio), ISSN 1083-7159, 02/2019, Volume 24, Issue S1, pp. S31 - S41
Clinical trials | Immune checkpoint inhibitors | PD‐1/PD‐L1 | Combination therapy | Non‐small‐cell lung cancer | Non-small-cell lung cancer | PD-1/PD-L1 | Life Sciences & Biomedicine | Oncology | Science & Technology | Lung Neoplasms - drug therapy | Immunotherapy - methods | Humans | Antibodies, Monoclonal - therapeutic use | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Clinical Trials as Topic | B7-H1 Antigen - immunology | Randomized Controlled Trials as Topic | Carcinoma, Non-Small-Cell Lung - immunology | Lung Neoplasms - immunology | B7-H1 Antigen - antagonists & inhibitors | China | Carcinoma, Non-Small-Cell Lung - drug therapy | Programmed Cell Death 1 Receptor - immunology | Antibodies, Monoclonal - immunology | Index Medicus | Lung Cancer | PD‐1 | PD‐L1
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Nivolumab in Advanced Hepatocellular Carcinoma: Safety Profile and Select Treatment‐Related Adverse Events From the CheckMate 040 Study
by Julien, Karen and Leung, Hiu Tung and Fuertes, Carmen and Mori, Megumi and Wang, Miao‐Jen and Teo, Jocelyn and Weiss, Lisa and Hamilton, Sara and DiFebo, Holly and Noh, Yoon Jin and Galway, Aralee and Koh, Jane and Brutcher, Edith and Zhao, Huanyu and Shen, Yun and Tschaika, Marina and To, Yue‐Yun
The oncologist (Dayton, Ohio), ISSN 1083-7159, 10/2020, Volume 25, Issue 10, pp. e1532 - e1540
Hepatocellular carcinoma | PD‐1 inhibitor | Adverse drug event | Immunotherapy | Nivolumab | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Effect of alkali metal auxiliary in HCHO oxidation on the model catalyst Na2O/Pd(1 1 1): A DFT study
by Zheng, Jianfeng and Shi, Hui and Xiang, Ning and Miao, Yulu and Zhang, Tao and Ge, Hui and Huang, Zhanggen
Applied surface science, ISSN 0169-4332, 09/2020, Volume 523, p. 146488
Alkali metal effect | DFT | Na2O | Pd(1 1 1) | HCHO catalytic oxidation
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Reversal of epigenetic aging and immunosenescent trends in humans
by Fahy, Gregory M and Brooke, Robert T and Watson, James P and Good, Zinaida and Vasanawala, Shreyas S and Maecker, Holden and Leipold, Michael D and Lin, David T. S and Kobor, Michael S and Horvath, Steve
Aging cell, ISSN 1474-9718, 12/2019, Volume 18, Issue 6, pp. e13028 - n/a
lymphocyte‐to‐monocyte ratio | naive T cells | thymic regeneration | PD‐1 | c-reactive protein | PSA | Life Sciences & Biomedicine | Geriatrics & Gerontology | Science & Technology | Cell Biology | Epigenetics | Aging | Life span | Morbidity | Age | Index Medicus | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Patient‐Reported Outcomes with PD‐1/PD‐L1 Inhibitors for Advanced Cancer: A Meta‐Analysis
by Nishijima, Tomohiro F and Shachar, Shlomit S and Muss, Hyman B and Tamura, Kazuo
The oncologist (Dayton, Ohio), ISSN 1083-7159, 07/2019, Volume 24, Issue 7, pp. e565 - e573
Patient‐reported outcomes | PD‐1/PD‐L1 inhibitor | Meta‐analysis | Health‐related quality of life | Symptoms | Health-related quality of life | Patient-reported outcomes | PD-1/PD-L1 inhibitor | Meta-analysis | Life Sciences & Biomedicine | Oncology | Science & Technology | Index Medicus | PD‐L1 inhibitor | Symptom Management and Supportive Care | PD‐1
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Immunotherapy in lung cancer
by Montenegro, Gabriela Bravo and Farid, Saira and Liu, Stephen V
Journal of surgical oncology, ISSN 0022-4790, 03/2021, Volume 123, Issue 3, pp. 718 - 729
chemo‐immunotherapy | neoadjuvant | PD‐1 | checkpoint inhibitors | PD‐L1 | Lung cancer | Immunotherapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights